Cargando…
Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis
OBJECTIVE: This study compared the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) with conventional taxanes as neoadjuvant chemotherapy for breast cancer. METHODS: We searched the literature using PubMed, the Cochrane Library, and Web of Science from their inception to...
Autores principales: | Li, Yong, Lu, Xiaoju, Lin, Qimou, Li, Weiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416144/ https://www.ncbi.nlm.nih.gov/pubmed/32762463 http://dx.doi.org/10.1177/0300060520943473 |
Ejemplares similares
-
Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials
por: Liu, Yun, et al.
Publicado: (2017) -
Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer
por: Li, Zhong-Hui, et al.
Publicado: (2022) -
Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients
por: Chen, Zhilan, et al.
Publicado: (2017) -
Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
por: Liu, Miao, et al.
Publicado: (2021) -
Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
por: Li, Zhen-Yu, et al.
Publicado: (2020)